CARLA PATRICIA
RÍOS LUCI
Investigadora en el periodo 2013-2015
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (2)
2019
-
TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
Cancer Letters, Vol. 453, pp. 34-44
2017
-
Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity
Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651